Analyst ratings and market activities have suggested a noticeable upward trend alongside buzz surrounding
Kellanova (NYSE:K). The biotech company's position was recently cut by
Cambridge Investment Research Advisors Inc and
Harbour Investments Inc. Despite this, Kellanova's stock jumped by 10% throughout a week due to talks about a takeover by candy manufacturer
Mars. This potential
$36 Billion Merger with Mars, a significant move in the snack foods industry, resulted in substantial stock surge for Kellanova. The major shareholder of Kellanova (NYSE:K) sold 77,800 shares, and the deployment came amid a period of high market performance for the company, with the stock reaching a new 12-month high at $80.75. Several investment firms such as
TrueMark Investments LLC and
Kintegral Advisory LLC also increased their holdings in Kellanova, and the biotech company's shares soared due to the buyout reports. According to an analyst, Kellanova could potentially be worth $108 per share in the takeover deal. DA Davidson and Royal Bank of Canada, however, downgraded Kellanova ratings to neutral.
Kellanova Stocks K News Analytics from Mon, 02 Oct 2023 07:00:00 GMT to Sun, 01 Sep 2024 08:38:22 GMT -
Rating 7
- Innovation 5
- Information 5
- Rumor -5
